The adipoinsular axis: Effects of leptin on pancreatic β-cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 278, Issue 1 41-1, 2000, Pages

  Kieffer, Timothy J ^a   Habener, Joel F ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diabetes; Insulin secretion

Indexed keywords

INSULIN; LEPTIN; LEPTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BODY FAT; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY EXPENDITURE; FEEDBACK SYSTEM; FOOD INTAKE; HUMAN; HUMAN TISSUE; INSULIN RELEASE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SATIETY;

EID: 0033974348     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.278.1.e1     Document Type: Review

References (189)

1. Ahima, R. S., D. Prabakaran, C. Mantzoros, D. Qu, B. Lowell, E. Maratos-Flier, and J. S. Flier. Role of leptin in the neuroendocrine response to fasting. Nature 382: 250-252, 1996.
2. Ahrén, B., and P. J. Havel. Leptin inhibits insulin secretion induced by cellular cAMP in INS-1 cells. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 277: R959-R966, 1999.
3. Ahren, B., H. Larsson, C. Wilhelmsson, B. Nasman, and T. Olsson. Regulation of circulating leptin in humans. Endocrine 7: 1-8, 1997.
4. Ashcroft, F. M., and P. Rorsman. Electrophysiology of the pancreatic β-cell. Prog. Biophys. Molec. Biol. 54: 87-143, 1989.
5. Auwerx, J., and B. Staels. Leptin. Lancet 351: 737-742, 1998.
6. Bado, A., S. Levasseur, S. Attoub, S. Kermorgant, J. P. Laigneau, M. N. Bortoluzzi, L. Moizo, T. Lehy, M. Guerre-Millo, Y. Le Marchand-Brustel, and M. J. Lewin. The stomach is a source of leptin. Nature 394: 790-793, 1998.
7. Bagdade, J. D. Basal insulin and obesity. Lancet 2: 630-631, 1968.
8. Barr, V. A., D. Malide, M. J. Zarnowski, S. I. Taylor, and S. W. Cushman. Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology 138: 4463-4472, 1997.
9. Barzilai, N., J. Wang, D. Massilon, P. Vuguin, M. Hawkins, and L. Rossetti. Leptin selectively decreases visceral adiposity and enhances insulin action. J. Clin. Invest. 100: 3105-3110, 1997.
10. Baumann, H., K. K. Morella, D. W. White, M. Dembski, P. S. Bailon, H. Kim, C. F. Lai, and L. A. Tartaglia. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA 93: 8374-8378, 1996.
11. Becker, D. J., L. N. Ongemba, V. Brichard, J. C. Henquin, and S. M. Brichard. Diet-and diabetes-induced changes of ob gene expression in rat adipose tissue. FEBS Lett. 371: 324-328, 1995.
12. +-stimulated nitro-phenyl phosphatase activity in the pancreatic islets of genetically diabetic mice (C57BL/KsJ-db/db). Diabetologia 15: 191-195, 1978.
13. Berti, L., M. Kellerer, E. Capp, and H. U. Haring. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a PI3-kinase mediated effect. Diabetologia 40: 606-609, 1997.
14. Bjorbaek, C., J. K. Elmquist, J. D. Frantz, S. E. Shoelson, and J. S. Flier. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1: 619-625, 1998.
15. Bjorbaek, C., S. Uotani, B. da Silva, and J. S. Flier. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 272: 32686-32695, 1997.
16. Branstrom, R., B. E. Corkey, P. O. Berggren, and O. Larsson. Evidence for a unique long chain acyl-CoA ester binding site on the ATP-regulated potassium channel in mouse pancreatic beta cells. J. Biol. Chem. 272: 17390-17394, 1997.
17. Campfield, L. A., F. J. Smith, Y. Guisez, R. Devos, and P. Burn. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549, 1995.
18. Carantoni, M., F. Abbasi, S. Azhar, Y. D. Chen, M. Klebanov, P. W. Wang, F. Warmerdam, and G. M. Reaven. Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance. Diabetes 47: 244-247, 1998.
19. Caro, J. F., M. K. Sinha, J. W. Kolaczynski, P. L. Zhang, and R. V. Considine. Leptin: the tale of an obesity gene. Diabetes 45: 1455-1462, 1996.
20. Cerasi, E. Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible? Diabetologia 38: 992-997, 1995.
21. Chen, H., O. Charlat, L. A. Tartaglia, E. A. Woolf, X. Weng, S. J. Ellis, N. D. Lakey, J. Culpepper, K. J. Moore, R. E. Breitbart, G. M. Duyk, R. I. Tepper, and J. P. Morgenstern. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495, 1996.
22. Chen, N.-G., and D. R. Romsos. Enhanced sensitivity of pancreatic islets from preobese 2-wk-old ob/ob mice to neurohormonal stimulation of insulin secretion. Endocrinology 136: 505-511, 1995.
23. Chen, N.-G., and D. R. Romsos. Persistently enhanced sensitivity of pancreatic islets from ob/ob mice to PKC-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. 272: E304-E311, 1997.
24. Chen, N. G., A. G. Swick, and D. R. Romsos. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice. J. Clin. Invest. 100: 1174-1179, 1997.
25. Chick, W. L., R. L. Lavine, and A. A. Like. Studies in the diabetic mutant mouse: V. Glucose tolerance in mice homozygous and heterozygous for the diabetes (db) gene. Diabetologia 6: 257-262, 1970.
26. Chinookoswong, N., J. L. Wang, and Z. Q. Shi. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 48: 1487-1492, 1999.
27. Chua, S. C., Jr., W. K. Chung, X. S. Wu-Peng, Y. Zhang, S. M. Liu, L. Tartaglia, and R. L. Leibel. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271: 994-996, 1996.
28. Coleman, D. L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14: 141-148, 1978.
29. Coleman, D. L. Diabetes-obesity syndromes in mice. Diabetes 31, Suppl. 1: 1-6, 1982.
30. Coleman, D. L., and K. P. Hummel. Hyperinsulinemia in pre-weaning diabetes (db) mice. Diabetologia 10: 607-610, 1974.
31. Coleman, R. A., and T. S. Herrmann. Nutritional regulation of leptin in humans. Diabetologia 42: 639-646, 1999.
32. Considine, R. V., and J. F. Caro. Leptin and the regulation of body weight. Int. J. Biochem. Cell Biol. 29: 1255-1272, 1997.
33. Considine, R. V., M. K. Sinha, M. L. Heiman, A. Kriauciunas, T. W. Stephens, M. R. Nyce, J. P. Ohannesian, C. C. Marco, L. J. McKee, T. L. Bauer, and J. F. Caro. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334: 292-295, 1996.
34. Cusin, I., A. Sainsbury, P. Doyle, F. Rohner-Jeanrenaud, and B. Jeanrenaud. The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 44: 1467-1470, 1995.
35. D'Adamo, M., A. Buongiorno, E. Maroccia, F. Leonetti, F. Barbetti, A. Giaccari, D. Zorretta, G. Tamburrano, and P. Sbraccia. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia. Diabetes 47: 1625-1629, 1998.
36. Dagogo-Jack, S., C. Fanelli, D. Paramore, J. Brothers, and M. Landt. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 45: 695-698, 1996.
37. Darnell, J. E., Jr. Reflections on STAT3, STAT5, and STAT6 as fat STATs. Proc. Natl. Acad. Sci. USA 93: 6221-6224, 1996.
38. DeFronzo, R. A. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35: 389-397, 1992.
39. DeFronzo, R. A., and E. Ferrannini. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
40. Diamond, F. B., Jr., D. C. Eichler, G. Duckett, E. V. Jorgensen, D. Shulman, and A. W. Root. Demonstration of a leptin binding factor in human serum. Biochem. Biophys. Res. Commun. 233: 818-822, 1997.
41. Drucker, D. J., J. Philippe, S. Mojsov, W. L. Chick, and J. F. Habener. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. USA 84: 3434-3438, 1987.
42. Dua, A., M. I. Hennes, R. G. Hoffmann, D. L. Maas, G. R. Krakower, G. E. Sonnenberg, and A. H. Kissebah. Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 45: 1635-1637, 1996.
43. Dubuc, P. U. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism 25: 1567-1574, 1976.
44. Emilsson, V., Y. L. Liu, M. A. Cawthorne, N. M. Morton, and M. Davenport. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46: 313-316, 1997.
45. Erickson, J. C., G. Hollopeter, and R. D. Palmiter. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274: 1704-1707, 1996.
46. Esler, M., M. Vaz, G. Collier, P. Nestel, G. Jennings, D. Kaye, D. Seals, and G. Lambert. Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet 351: 879, 1998.
47. Fajas, L., J.-C. Fruchart, and J. Auwerx. Transcriptional control of adipogenesis. Curr. Opin. Cell. Biol. 10: 165-173, 1998.
48. Fehmann, H. C., P. Berghofer, D. Brandhorst, H. Brandhorst, B. Hering, R. G. Bretzel, and B. Goke. Leptin inhibition of insulin secretion from isolated human islets. Acta Diabetol. 34: 249-252, 1997.
49. Fehmann, H. C., H. P. Bode, T. Ebert, A. Karl, and B. Goke. Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction. Horm. Metab. Res. 29: 572-576, 1997.
50. Fehmann, H. C., and J. F. Habener. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in βTC-1 insulinoma cells. Endocrinology 130: 159-166, 1992.
51. Fehmann, H. C., C. Peiser, H. P. Bode, M. Stamm, P. Staats, C. Hedetoft, R. E. Lang, and B. Goke. Leptin: a potent inhibitor of insulin secretion. Peptides 18: 1267-1273, 1997.
52. Fei, H., H. J. Okano, C. Li, G. H. Lee, C. Zhao, R. Darnell, and J. M. Friedman. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl. Acad. Sci. USA 94: 7001-7005, 1997.
53. Ferrannini, E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr. Rev. 19: 477-490, 1998.
54. Ferrannini, E., A. Natali, P. Bell, P. Cavallo-Perin, N. Lalic, G. Mingrone, and the European Group for the Study of Insulin Resistance (EGIR). Insulin resistance and hypersecretion in obesity. J. Clin. Invest. 100: 1166-1173, 1997.
55. Flatt, P. R., C. J. Bailey, A. M. Cameron, and B. J. Gould. Age effects on glycosylated blood proteins in lean and obese hyperglycaemic (ob/ob) mice. Diabetes Res. 3: 241-243, 1986.
56. Flier, J. S. Leptin expression and action: new experimental paradigms. Proc. Natl. Acad. Sci. USA 94: 4242-4245, 1997.
57. Flier, J. S. Clinical review 94: What's in a name? In search of leptin's physiologic role. J. Clin. Endocrinol. Metab. 83: 1407-1413, 1998.
58. + channels of pancreatic β-cells of lean and obese (ob / ob) C57BL/6J mice. J. Membrane Biol. 129: 267-276, 1992.
59. +-induced membrane depolarization on insulin secretion in islets of lean and obese (ob / ob) mice. Biochem. Cell. Biol. 68: 243-248, 1990.
60. Friedman, J. M. Leptin, leptin receptors, and the control of body weight. Nutr. Rev. 56: 38-46; 54-75, 1998.
61. Friedman, J. M., and J. L. Halaas. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
62. Genuth, S. M. Hyperinsulinism in mice with genetically determined obesity. Endocrinology 84: 386-391, 1969.
63. Genuth, S. M., R. J. Przybylski, and D. M. Rosenberg. Insulin resistance in genetically obese, hyperglycemic mice. Endocrinology 88: 1230-1238, 1971.
64. Gettys, T. W., P. J. Harkness, and P. M. Watson. The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 137: 4054-4057, 1996.
65. Ghilardi, N., and R. C. Skoda. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol. 11: 393-399, 1997.
66. Ghilardi, N., S. Ziegler, A. Wiestner, R. Stoffel, M. H. Heim, and R. C. Skoda. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 93: 6231-6235, 1996.
67. Groop, L. C., E. Widen, and E. Ferrannini. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36: 1326-1331, 1993.
68. Grundleger, M. L., V. Y. Godbole, and S. W. Thenen. Age-dependent development of insulin resistance of soleus muscle in genetically obese (ob / ob) mice. Am. J. Physiol. Endocrinol. Metab. 239: E363-E371, 1980.
69. Halaas, J. L., K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait, D. Rabinowitz, R. L. Lallone, S. K. Burley, and J. M. Friedman. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
70. Hardie, L. J., N. Guilhot, and P. Trayhurn. Regulation of leptin production in cultured mature white adipocytes. Horm. Metab. Res. 28: 685-689, 1996.
71. Harris, R. B. Acute and chronic effects of leptin on glucose utilization in lean mice. Biochem. Biophys. Res. Commun. 245: 502-509, 1998.
72. Harris, R. B., J. Zhou, S. M. Redmann, Jr., G. N. Smagin, S. R. Smith, E. Rodgers, and J. J. Zachwieja. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 139: 8-19, 1998.
73. Harvey, J., and M. L. Ashford. Diazoxide-and leptin-activated K(ATP) currents exhibit differential sensitivity to englitazone and ciclazindol in the rat CRI-G1 insulin-secreting cell line. Br. J. Pharmacol. 124: 1557-1565, 1998.
74. Harvey, J., and M. L. Ashford. Insulin occludes leptin activation of ATP-sensitive K+ channels in rat CRI-G1 insulin secreting cells. J. Physiol. (Lond.) 511: 695-706, 1998.
75. Harvey, J., and M. L. Ashford. Role of tyrosine phosphorylation in leptin activation of ATP-sensitive K+ channels in the rat insulinoma cell line CRI-G1. J. Physiol. (Lond.) 510: 47-61, 1998.
76. Harvey, J., F. McKenna, P. S. Herson, D. Spanswick, and M. L. Ashford. Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1. J. Physiol. (Lond.) 504: 527-535, 1997.
77. Havel, P. J., S. Kasim-Karakas, W. Mueller, P. R. Johnson, R. L. Gingerich, and J. S. Stern. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J. Clin. Endocrinol. Metab. 81: 4406-4413, 1996.
78. Havel, P. J., J. Y. Uriu-Hare, T. Liu, K. L. Stanhope, J. S. Stern, C. L. Keen, and B. Ahren. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 274: R1482-R1491, 1998.
79. Herberg, L., and D. L. Coleman. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 26: 59-99, 1977.
80. Hoggard, N., J. G. Mercer, D. V. Rayner, K. Moar, P. Trayhurn, and L. M. Williams. Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochem. Biophys. Res. Commun. 232: 383-387, 1997.
81. Holz, G. G., and J. F. Habener. Signal transduction crosstalk in the endocrine system: pancreatic beta-cells and the glucose competence concept. Trends Biochem. Sci. 17: 388-393, 1992.
82. Holz, G. G., IV, W. M. Kühtreiber, and J. F. Habener. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361: 362-365, 1993.
83. Houseknecht, K. L., C. A. Baile, R. L. Matteri, and M. E. Spurlock. The biology of leptin: a review. J. Anim. Sci. 76: 1405-1420, 1998.
84. Houseknecht, K. L., C. S. Mantzoros, R. Kuliawat, E. Hadro, J. S. Flier, and B. B. Kahn. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 45: 1638-1643, 1996.
85. Hwang, C. S., T. M. Loftus, S. Mandrup, and M. D. Lane. Adipocyte differentiation and leptin expression. Annu. Rev. Cell. Dev. Biol. 13: 231-259, 1997.
86. Igel, M., H. Kainulainen, A. Brauers, W. Becker, L. Herberg, and H. G. Joost. Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese (db/db mice, fa/fa rats) rodents. Diabetologia 39: 758-765, 1996.
87. Ishida, K., T. Murakami, A. Mizuno, M. Iida, M. Kuwajima, and K. Shima. Leptin suppresses basal insulin secretion from rat pancreatic islets. Regul. Pept. 70: 179-182, 1997.
88. Ishikawa, M., M. L. Pruneda, B. Adams-Huet, and P. Raskin. Obesity-independent hyperinsulinemia in nondiabetic first-degree relatives of individuals with type 2 diabetes. Diabetes 47: 788-792, 1998.
89. Islam, M. S., N. M. Morton, A. Hansson, and V. Emilsson. Rat insulinoma-derived pancreatic beta-cells express a functional leptin receptor that mediates a proliferative response. Biochem. Biophys. Res. Commun. 238: 851-855, 1997.
90. Kahn, B. B. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 92: 593-596, 1998.
91. Kahn, C. R. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084, 1994.
92. Kamohara, S., R. Burcelin, J. L. Halaas, J. M. Friedman, and M. J. Charron. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377, 1997.
93. Karlsson, E., M. Stridsberg, and S. Sandler. Leptin regulation of islet amyloid polypeptide secretion from mouse pancreatic islets. Biochem. Pharmacol. 56: 1339-1346, 1998.
94. Kieffer, T. J., R. S. Heller, and J. F. Habener. Leptin receptors expressed on pancreatic beta-cells. Biochem. Biophys. Res. Commun. 224: 522-527, 1996.
95. Kieffer, T. J., R. S. Heller, C. A. Leech, G. G. Holz, and J. F. Habener. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes 46: 1087-1093, 1997.
96. Kim, J. B., P. Sarraf, M. Wright, K. M. Yao, E. Mueller, G. Solanes, B. B. Lowell, and B. M. Spiegelman. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J. Clin. Invest. 101: 1-9, 1998.
97. Kline, A. D., G. W. Becker, L. M. Churgay, B. E. Landen, D. K. Martin, W. L. Muth, R. Rathnachalam, J. M. Richardson, B. Schoner, M. Ulmer, and J. E. Hale. Leptin is a four-helix bundle: secondary structure by NMR. FEBS Lett. 407: 239-242, 1997.
98. Kolaczynski, J. W., R. V. Considine, J. Ohannesian, C. Marco, I. Opentanova, M. R. Nyce, M. Myint, and J. F. Caro. Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 45: 1511-1515, 1996.
99. Kolaczynski, J. W., M. R. Nyce, R. V. Considine, G. Boden, J. J. Nolan, R. Henry, S. R. Mudaliar, J. Olefsky, and J. F. Caro. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 45: 699-701, 1996.
100. Koopmans, S. J., M. Frolich, E. H. Gribnau, R. G. Westendorp, and R. A. DeFronzo. Effect of hyperinsulinemia on plasma leptin concentrations and food intake in rats. Am. J. Physiol. Endocrinol. Metab. 274: E998-E1001, 1998.
101. Koyama, K., G. Chen, M. Y. Wang, Y. Lee, M. Shimabukuro, C. B. Newgard, and R. H. Unger. β-Cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes 46: 1276-1280, 1997.
102. Kukuljan, M., M. Y. Li, and I. Atwater. Characterization of potassium channels in pancreatic βcells from ob / ob mice. FEBS Lett. 266: 105-108, 1990.
103. Kulkarni, R. N., Z. L. Wang, R. M. Wang, J. D. Hurley, D. M. Smith, M. A. Ghatei, D. J. Withers, J. V. Gardiner, C. J. Bailey, and S. R. Bloom. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J. Clin. Invest. 100: 2729-2736, 1997.
104. Larsson, H., S. Elmstahl, and B. Ahren. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 45: 1580-1584, 1996.
105. Larsson, O., J. T. Deeney, R. Branstrom, P. O. Berggren, and B. E. Corkey. Activation of the ATP-sensitive K+ channel by long chain acyl-CoA. A role in modulation of pancreatic beta-cell glucose sensitivity. J. Biol. Chem. 271: 10623-10626, 1996.
106. Le Stunff, C., and P. Bougnères. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes 43: 696-702, 1994.
107. Leclercq-Meyer, V., R. V. Considine, A. Sener, and W. J. Malaisse. Do leptin receptors play a functional role in the endocrine pancreas? Biochem. Biophys. Res. Commun. 229: 794-798, 1996.
108. Leclercq-Meyer, V., and W. J. Malaisse. Failure of leptin to counteract the effects of glucose on insulin and glucagon release by the perfused rat pancreas. Med. Sci. Res. 25: 257-259, 1997.
109. Leclercq-Meyer, V., and W. J. Malaisse. Failure of human and mouse leptin to affect insulin, glucagon and somatostatin secretion by the perfused rat pancreas at physiological glucose concentration. Mol. Cell. Endocrinol. 141: 111-118, 1998.
110. Lee, G. H., R. Proenca, J. M. Montez, K. M. Carroll, J. G. Darvishzadeh, J. I. Lee, and J. M. Friedman. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635, 1996.
111. Leroy, P., S. Dessolin, P. Villageois, B. C. Moon, J. M. Friedman, G. Ailhaud, and C. Dani. Expression of ob gene in adipose cells. Regulation by insulin. J. Biol. Chem. 271: 2365-2368, 1996.
112. Levin, N., C. Nelson, A. Gurney, R. Vandlen, and F. de Sauvage. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc. Natl. Acad. Sci. USA 93: 1726-1730, 1996.
113. Li, H. Y., L. L. Wang, and R. S. Yeh. Leptin immunoreactivity in the central nervous system in normal and diabetic rats. Neuroreport 10: 437-442, 1999.
114. Lin, P. Y., D. R. Romsos, and G. A. Leveille. Food intake, body weight gain, and body composition of the young obese (ob/ob) mouse. J. Nutr. 107: 1715-1723, 1977.
115. Lollmann, B., S. Gruninger, A. Stricker-Krongrad, and M. Chiesi. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem. Biophys. Res. Commun. 238: 648-652, 1997.
116. Luo, G., and L. Yu-Lee. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters. J. Biol. Chem. 272: 26841-26849, 1997.
117. MacDougald, O. A., C. S. Hwang, H. Fan, and M. D. Lane. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 92: 9034-9037, 1995.
118. Maffei, M., J. Halaas, E. Ravussin, R. E. Pratley, G. H. Lee, Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1: 1155-1161, 1995.
119. Malmstrom, R., M. R. Taskinen, S. L. Karonen, and H. Yki-Jarvinen. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 39: 993-996, 1996.
120. Masuzaki, H., Y. Ogawa, N. Sagawa, K. Hosoda, T. Matsumoto, H. Mise, H. Nishimura, Y. Yoshimasa, I. Tanaka, T. Mori, and K. Nakao. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat. Med. 3: 1029-1033, 1997.
121. McGregor, G. P., J. F. Desaga, K. Ehlenz, A. Fischer, F. Heese, A. Hegele, C. Lammer, C. Peiser, and R. E. Lang. Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 137: 1501-1504, 1996.
122. Meissner, H. P., and H. Schmidt. The electrical activity of pancreatic beta-cells of diabetic mice. FEBS Lett. 67: 371-374, 1976.
123. Mizuno, A., T. Murakami, S. Otani, M. Kuwajima, and K. Shima. Leptin affects pancreatic endocrine functions through the sympathetic nervous system. Endocrinology 139: 3863-3870, 1998.
124. Morton, N. M., V. Emilsson, R. P. de Groot, A. L. Pallet, and M. A. Cawthorne. Leptin signalling in pancreatic islets and clonal insulin-secreting cells. J. Mol. Endocrinol. 22: 173-184, 1999.
125. Morton, N. M., V. Emilsson, Y. L. Liu, and M. A. Cawthorne. Leptin action in intestinal cells. J. Biol. Chem. 273: 26194-26201, 1998.
126. Mueller, W. M., F. M. Gregoire, K. L. Stanhope, C. V. Mobbs, T. M. Mizuno, C. H. Warden, J. S. Stern, and P. J. Havel. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology 139: 551-558, 1998.
127. Murakami, T., T. Yamashita, M. Iida, M. Kuwajima, and K. Shima. A short form of leptin receptor performs signal transduction. Biochem. Biophys. Res. Commun. 231: 26-29, 1997.
128. Muzzin, P., R. C. Eisensmith, K. C. Copeland, and S. L. Woo. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc. Natl. Acad. Sci. USA 93: 14804-14808, 1996.
129. Nolan, J. J., J. M. Olefsky, M. R. Nyce, R. V. Considine, and J. F. Caro. Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes 45: 1276-1278, 1996.
130. Odeleye, O. E., M. de Courten, D. J. Pettitt, and E. Ravussin. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 46: 1341-1345, 1997.
131. Olefsky, J. M., and J. J. Nolan. Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. Am. J. Clin. Nutr. 61: 980S-986S, 1995.
132. Ookuma, M., K. Ookuma, and D. A. York. Effects of leptin on insulin secretion from isolated rat pancreatic islets. Diabetes 47: 219-223, 1998.
133. Pallett, A. L., N. M. Morton, M. A. Cawthorne, and V. Emilsson. Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets. Biochem. Biophys. Res. Commun. 238: 267-270, 1997.
134. Patel, B. K., J. I. Koenig, L. M. Kaplan, and S. C. Hooi. Increase in plasma leptin and Lep mRNA concentrations by food intake is dependent on insulin. Metabolism 47: 603-607, 1998.
135. Pelleymounter, M. A., M. J. Cullen, M. B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995.
136. Poitout, V., C. Rouault, M. Guerre-Millo, I. Briaud, and G. Reach. Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans. Endocrinology 139: 822-826, 1998.
137. Polonsky, K. S., B. D. Given, L. Hirsch, E. T. Shapiro, H. Tillil, C. Beebe, J. A. Galloway, B. H. Frank, T. Karrison, and E. Van Cauter. Quantitative study of insulin secretion and clearance in normal and obese subjects. J. Clin. Invest. 81: 435-441, 1988.
138. Popovic, V., D. Micic, S. Danjanovic, S. Zoric, M. Djurovic, S. Obradovic, M. Petakov, C. Dieguez, and F. F. Casanueva. Serum leptin and insulin concentrations in patients with insulinoma before and after surgery. Eur. J. Endocrinol. 138: 86-88, 1998.
139. Prentki, M., K. Tornheim, and B. E. Corkey. Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 40: S32-S41, 1997.
140. Prevarskaya, N. B., R. N. Skryma, P. Vacher, N. Daniel, J. Djiane, and B. Dufy. Role of tyrosine phosphorlation in potassium channel activation: functional association with prolactin receptor and JAK2 tyrosine kinase. J. Biol. Chem. 270: 24292-24299, 1995.
141. Reaven, G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
142. Reaven, G. M., and A. Laws. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 37: 948-952, 1994.
143. Rentsch, J., and M. Chiesi. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett. 379: 55-59, 1996.
144. Roduit, R., and B. Thorens. Inhibition of glucose-induced insulin secretion by long-term preexposure of pancreatic islets to leptin. FEBS Lett. 415: 179-182, 1997.
145. + permeability. Q. J. Exp. Physiol. 70: 137-150, 1985.
146. Rosenblum, C. I., M. Tota, D. Cully, T. Smith, R. Collum, S. Qureshi, J. F. Hess, M. S. Phillips, P. J. Hey, A. Vongs, T. M. Fong, L. Xu, H. Y. Chen, R. G. Smith, C. Schindler, and L. H. Van der Ploeg. Functional STAT 1 and 3 signaling by the leptin receptor (OB-R); reduced expression of the rat fatty leptin receptor in transfected cells. Endocrinology 137: 5178-5181, 1996.
147. Rossetti, L., D. Massillon, N. Barzilai, P. Vuguin, W. Chen, M. Hawkins, J. Wu, and J. Wang. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J. Biol. Chem. 272: 27758-27763, 1997.
148. Russell, C. D., R. N. Petersen, S. P. Rao, M. R. Ricci, A. Prasad, Y. Zhang, R. E. Brolin, and S. K. Fried. Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone. Am. J. Physiol. Endocrinol. Metab. 275: E507-E515, 1998.
149. Saad, M. F., A. Khan, A. Sharma, R. Michael, M. G. Riad-Gabriel, R. Boyadjian, S. D. Jinagouda, G. M. Steil, and V. Kamdar. Physiological insulinemia acutely modulates plasma leptin. Diabetes 47: 544-549, 1998.
150. Saladin, R., P. De Vos, M. Guerre-Millo, A. Leturque, J. Girard, B. Staels, and J. Auwerx. Transient increase in obese gene expression after food intake or insulin administration. Nature 377: 527-529, 1995.
151. Schwartz, M. W., D. G. Baskin, T. R. Bukowski, J. L. Kuijper, D. Foster, G. Lasser, D. E. Prunkard, D. Porte, Jr., S. C. Woods, R. J. Seeley, and D. S. Weigle. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45: 531-535, 1996.
152. Seufert, J., T. J. Kieffer, and J. F. Habener. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deflcient ob / ob mice. Proc. Natl. Acad. Sci. USA 96: 674-679, 1999.
153. Seufert, J., T. J. Kieffer, C. A. Leech, G. G. Holz, W. Moritz, C. Ricordi, and J. F. Habener. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J. Clin. Endocrinol. Metab. 84: 670-676, 1999.
154. Shi, Z. Q., A. Nelson, L. Whitcomb, J. Wang, and A. M. Cohen. Intracerebroventricular administration of leptin markedly enhances insulin sensitivity and systemic glucose utilization in conscious rats. Metabolism 47: 1274-1280, 1998.
155. Shimabukuro, M., M. Higa, Y. T. Zhou, M. Y. Wang, C. B. Newgard, and R. H. Unger. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J. Biol. Chem. 273: 32487-32490, 1998.
156. Shimabukuro, M., K. Koyama, G. Chen, M. Y. Wang, F. Trieu, Y. Lee, C. B. Newgard, and R. H. Unger. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA 94: 4637-4641, 1997.
157. Shimizu, H., K. Ohtani, T. Tsuchiya, H. Takahashi, Y. Uehara, N. Sato, and M. Mori. Leptin stimulates insulin secretion and synthesis in HIT-T 15 cells. Peptides 18: 1263-1266, 1997.
158. Siegrist-Kaiser, C. A., V. Pauli, C. E. Juge-Aubry, O. Boss, A. Pernin, W. W. Chin, I. Cusin, F. Rohner-Jeanrenaud, A. G. Burger, J. Zapf, and C. A. Meier. Direct effects of leptin on brown and white adipose tissue. J. Clin. Invest. 100: 2858-2864, 1997.
159. Sigal, R. J., M. El-Hashimy, B. C. Martin, S. Soeldner, A. S. Krolewski, and J. H. Warram. Acute postchallenge hyperinsulinemia predicts weight gain. A prospective study. Diabetes 46: 1025-1029, 1997.
160. Sinha, M. K., J. P. Ohannesian, M. L. Heiman, A. Kriauciunas, T. W. Stephens, S. Magosin, C. Marco, and J. F. Caro. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J. Clin. Invest. 97: 1344-1347, 1996.
161. Sinha, M. K., I. Opentanova, J. P. Ohannesian, J. W. Kolaczynski, M. L. Heiman, J. Hale, G. W. Becker, R. R. Bowsher, T. W. Stephens, and J. F. Caro. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J. Clin. Invest. 98: 1277-1282, 1996.
162. Sivitz, W. I., S. Walsh, D. Morgan, P. Donohoue, W. Haynes, and R. L. Leibel. Plasma leptin in diabetic and insulin-treated diabetic and normal rats. Metabolism 47: 584-591, 1998.
163. Sivitz, W. I., S. A. Walsh, D. A. Morgan, M. J. Thomas, and W. G. Haynes. Effects of leptin on insulin sensitivity in normal rats. Endocrinology 138: 3395-3401, 1997.
164. Slieker, L. J., K. W. Sloop, P. L. Surface, A. Kriauciunas, F. LaQuier, J. Manetta, J. Bue-Valleskey, and T. W. Stephens. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J. Biol. Chem. 271: 5301-5304, 1996.
165. Spanswick, D., M. A. Smith, V. E. Groppi, S. D. Logan, and M. L. Ashford. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390: 521-525, 1997.
166. Stephens, T. W., M. Basinski, P. K. Bristow, J. M. Bue-Valleskey, S. G. Burgett, L. Craft, J. Hale, J. Hoffmann, H. M. Hsiung, A. Kriauciunas, W. MacKellar, P. R. J. Rosteck, B. Schoner, D. Smith, F. C. Tinsley, X.-Y. Zhang, and M. Heiman. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532, 1995.
167. Stout, R. W. Insulin and atheroma: 20-years perspective. Diabetes Care 13: 631-654, 1990.
168. Tanabe, K., S. Okuya, Y. Tanizawa, A. Matsutani, and Y. Oka. Leptin induces proliferation of pancreatic beta cell line MIN6 through activation of mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 241: 765-768, 1997.
169. Tanizawa, Y., S. Okuya, H. Ishihara, T. Asano, T. Yada, and Y. Oka. Direct stimulation of basal insulin secretion by physiological concentrations of leptin in pancreatic beta cells. Endocrinology 138: 4513-4516, 1997.
170. Tartaglia, L. A. The leptin receptor. J. Biol. Chem. 272: 6093-6096, 1997.
171. Tartaglia, L. A., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos,
172. Taylor, S. I., D. Accili, and Y. Imai. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43: 735-740, 1994.
173. Unger, R. H., Y.-T. Zhou, and L. Orci. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc. Natl. Acad. Sci. USA 96: 2327-2332, 1999.
174. Utriainen, T., R. Malmstrom, S. Makimattila, and H. Yki-Jarvinen. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes 45: 1364-1366, 1996.
175. Vaisse, C., J. L. Halaas, C. M. Horvath, J. E. Darnell, Jr., M. Stoffel, and J. M. Friedman. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14: 95-97, 1996.
176. Vidai, H., D. Auboeuf, P. De Vos, B. Staels, J. P. Riou, J. Auwerx, and M. Laville. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J. Clin. Invest. 98: 251-255, 1996.
177. Wabitsch, M., P. B. Jensen, W. F. Blum, C. T. Christoffersen, P. Englaro, E. Heinze, W. Rascher, W. Teller, H. Tornqvist, and H. Hauner. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 45: 1435-1438, 1996.
178. Wang, J., R. Liu, M. Hawkins, N. Barzilai, and L. Rossetti. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393: 684-688, 1998.
179. Wang, J. L., N. Chinookoswong, S. Scully, M. Qi, and Z. Q. Shi. Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology 140: 2117-2124, 1999.
180. Wang, M. Y., K. Koyama, M. Shimabukuro, D. Mangelsdorf, C. B. Newgard, and R. H. Unger. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proc. Natl. Acad. Sci. USA 95: 11921-11926, 1998.
181. Wang, M. Y., K. Koyama, M. Shimabukuro, C. B. Newgard, and R. H. Unger. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc. Natl. Acad. Sci. USA 95: 714-718, 1998.
182. Weigle, D. S., T. R. Bukowski, D. C. Foster, S. Holderman, J. M. Kramer, G. Lasser, C. E. Lofton-Day, D. E. Prunkard, C. Raymond, and J. L. Kuijper. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 96: 2065-2070, 1995.
183. White, D. W., K. K. Kuropatwinski, R. Devos, H. Baumann, and L. A. Tartaglia. Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J. Biol. Chem. 272: 4065-4071, 1997.
184. White, D. W., and L. A. Tartaglia. Evidence for ligand-independent homo-oligomerization of leptin receptor (OB-R) isoforms: a proposed mechanism permitting productive long-form signaling in the presence of excess short-form expression. J. Cell. Biochem. 73: 278-288, 1999.
185. Yoshida, T., M. Hayashi, T. Monkawa, and T. Saruta. Regulation of obese mRNA expression by hormonal factors in primary cultures of rat adipocytes. Eur. J. Endocrinol. 135: 619-625, 1996.
186. Zawalich, W. S., M. Bonnet-Eymard, and K. C. Zawalich. Signal transduction in pancreatic beta-cells: regulation of insulin secretion by information flow in the phospholipase C/protein kinase C pathway. Front. Biosci. 2: d160-d172, 1997.
187. Zhang, F., M. B. Basinski, J. M. Beals, S. L. Briggs, L. M. Churgay, D. K. Clawson, R. D. DiMarchi, T. C. Furman, J. E. Hale, H. M. Hsiung, B. E. Schoner, D. P. Smith, X. Y. Zhang, J. P. Wery, and R. W. Schevitz. Crystal structure of the obese protein leptin-E100. Nature 387: 206-209, 1997.
188. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. Friedman. Positional cloning of the mouse obese gene and its human homolog. Nature 372: 425-432, 1994.
189. Zhao, A. Z., K. E. Bornfeldt, and J. A. Beavo. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J. Clin. Invest. 102: 869-873, 1998.